Kitov Pharma (KTOV) stock is up more than 15% Friday, rising as high as $1.63, which is 48.2% higher than Thursday’s closing price of $1.10. KTOV stock is down -43.30% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives KTOV stock a score of 64 out of a possible 100.
That score is chiefly influenced by a fundamental score of 90. In addition to the average rating from Wall Street analysts, KTOV stock has a mean target price of $12.00. This means analysts expect the stock to increase 844.88% over the next 12 months. KTOV’s score also includes a short-term technical score of 55. The long-term technical score for KTOV is 46.
What’s Happening with KTOV Stock Today
Kitov Pharma (KTOV) stock is up 15.45% while the S&P 500 is higher by 0.58% as of 2:00 PM on Friday, Apr 12. KTOV is higher by $0.17 from the previous closing price of $1.10 on volume of 21,474,064 shares. Over the past year the S&P 500 has gained 9.94% while KTOV is down -43.30%. KTOV lost -$0.07 per share in the over the last 12 months.